Alendronate is used to treat osteoporosis, and it has been previously tested as an inhibitor of T. cruzi farnesyl diphosphate synthase [11,12], whereas flucytosine, an antifungal drug, has also not been tested against T. cruzi. The gene discussed is FDPS; the disease is osteoporosis.